Government-run hospitals still the mainstay of India vaccination drive
While private hospitals can conduct vaccinations on all days, government health facilities are required to carry out vaccinations for a minimum of four days and a maximum of six days a week. Government hospitals also have the additional responsibility of other public immunisation initiatives. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech's Covaxin gets restricted emergency nod
Out of the total vaccination, Covaxin has so far been given to 19 lakh people, Paul said. Paul said the vaccine has stood the test of time in terms of safety as only 311 people had reported side effects, that too minimal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Govt approves 33 API applications with over Rs 5,000 cr committed investment under PLI scheme
Department of Pharma has launched a PLI scheme for the promotion of domestic manufacturing by setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Drugs Controller General accepts expert committee report to allow Covaxin jabs without clinical trial
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Pfizer jab 97% effective against symptomatic Covid: Study
Using data from January 17 to March 6 from Israel's national vaccination campaign, Pfizer-Biontech found that prevention against asymptomatic disease also reached 94 percent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Five things to know about the AstraZeneca/Oxford vaccine
​Denmark said on Thursday it would suspend use of the AstraZeneca vaccine as precautionary measure over fears of blood clots in vaccinated people. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Lupin launches generic diarrhea drug in US market
Nitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets 3 observations from USFDA for US-based API plant
The audit of the company's active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed by the US Food and Drug Administration (USFDA), the Hyderabad-based drug major said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Increased outreach is helping create long term value for India's big pharma
In recent years, there has been a conscious attempt by companies to increase visibility in the form of increased patient outreach, higher investments on brands, and rising corporate communication through social media along with corporate legacy development efforts through book launches. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Pfizer wants to make vaccine in India if faster clearance, export freedom assured: Sources
The U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

DGCI's Subject Expert Committee recommends waiving off 'clinical trial mode' from Covaxin
After more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinical trial mode from Covaxin on the basis of the efficacy data that was presented by the company before the SEC. Hyderabad-based Bharat Biotech had approached the drug regulator for the removal of Covaxin vaccine from “clinical trial mode” and review the interim analysis of its phase-3 trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

WTO to take up India, South Africa's intellectual property waiver plea for COVID-19 vaccine
The World Trade Organization will once again take up the proposal of India and South Africa on Wednesday and Thursday to drop certain provisions of the TRIPS agreement for Covid drugs, diagnostics and therapeutics until the end of the pandemic. More than 80 countries have backed this proposal, even as big pharma and high-income countries and regions such as the European Union, the US and Canada continue to raise objections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Covaxin safe, may be superior to similar vaccines: Lancet
India ’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journal Lancet has said while publishing the vaccine’s phase 2 trial results. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Decision on vaccine must be left to 'executive's wisdom': HC
A bench of Chief Justice Dipankar Datta and Justice G S Kulkarni was hearing a plea filed by Mumbai-based lawyers, seeking that members of the judiciary, advocates and their staff be considered as frontline workers and they be provided vaccine against COVID-19 on a priority basis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Meril Life Sciences launches indigenously developed bioresorbable scaffold
This novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, sequential manner to ensure adherence to best clinical practices and continued development of clinical research and long-term evidence, Meril Life Sciences said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Lupin Pharma partners with Endoceutics to commercialise Intrarosa in Canada
Intrarosa is Endoceutic's flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech's COVID-19 vaccine, Covaxin, has no serious side effects, says The Lancet
However, the report made it clear that efficacy cannot be determined by phase 2 trials and this required further corroboration with phase 3 safety results. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2021 Category: Pharmaceuticals Source Type: news

Teva launches Indoco Remedies-developed generic drug in US
​​The product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its Goa facility for Teva. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech approaches DCGI, seeks Covaxin's removal from 'clinical trial mode'
The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode”, which meant that beneficiaries would have to give consent before they were vaccinated and there would be regular follow up. Such persons would also not receive the placebo. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2021 Category: Pharmaceuticals Source Type: news

Pfizer Covid shot neutralises Brazilian strain in lab study
In lab experiments, the shot demonstrated “roughly equivalent” levels of neutralising activity against the Brazil and UK strains compared with a version of the virus from early last year. It also showed “robust but lower” activity against the South Africa variant, according to a letter to the New England Journal of Medicine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2021 Category: Pharmaceuticals Source Type: news

Natco's marketing partner gets USFDA nod for cancer treatment drug
"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets from the US Food and Drug Administration (USFDA)," Natco Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2021 Category: Pharmaceuticals Source Type: news

Piramal Pharma enters feminine intimate care segment
The company has launched 'i-feel Gentle Intimate Wash' which would be initially available in the West Bengal market and on all leading e-commerce platforms. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2021 Category: Pharmaceuticals Source Type: news

Vaishali Pharma gets orders from Vanuatu Islands, Samoa Islands
Vanuatu is a South Pacific Ocean nation made up of roughly 80 islands. The need for healthcare products is increasing in Vanuatu islands due to increasing rates of non-communicable diseases (NCDs). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2021 Category: Pharmaceuticals Source Type: news

Vivimed Labs gets approval from Uzbekistan govt for two products
The company has received approval for Bilastin tablets, which are used for the treatment of allergic Rhino conjunctivitis and Urticaria, the Hyderabad-based company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2021 Category: Pharmaceuticals Source Type: news

Oral Covid treatment yields promising trial data, say drugmakers
German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients' viral load. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 7, 2021 Category: Pharmaceuticals Source Type: news

Need to step up funding for health sector, bring equity in delivery of services: Harsh Vardhan
“A radical improvement in government facilities for the poor rather than only glitzy hospitals for the well-heeled along with the recent moves to lower prices of essential drugs and health equipment, are steps in the right direction,” a statement quoted the minister as saying at an event. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 6, 2021 Category: Pharmaceuticals Source Type: news

What do vaccine efficacy numbers actually mean?
Efficacy is a crucial concept in vaccine trials, but it ’s also a tricky one. If a vaccine has an efficacy of, say, 95%, that doesn’t mean that 5% of people who receive that vaccine will get COVID-19. And just because one vaccine ends up with a higher efficacy estimate than another in trials doesn’t necessarily mean it’s superior. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 6, 2021 Category: Pharmaceuticals Source Type: news

Glenmark Pharma signs Rohit Sharma as brand ambassador
Rohit Sharma has "officially signed on to represent Glenmark's Candid Powder, a legacy brand of the company's consumer care division", the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2021 Category: Pharmaceuticals Source Type: news

Shilpa Medicare gets tentative American health regulator nod for Apremilast tablets
The company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast tablets in the strengths of 10 mg, 20 mg, and 30 mg, Shilpa Medicare said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2021 Category: Pharmaceuticals Source Type: news

US export curbs can limit COVID-19 vaccine production, availability: SII CEO Adar Poonawalla
SII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the Novavax shot. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2021 Category: Pharmaceuticals Source Type: news

Oxford study indicates AstraZeneca effective against Brazil variant, source says
The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus, said the source, who requested anonymity as the results have not yet been made public. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2021 Category: Pharmaceuticals Source Type: news

After India jabs millions, its COVID-19 vaccine shows potency
Covaxin had been approved by government officials in January and administered to millions of people before it had been publicly proved to be safe or effective. Many people in India, including frontline health care workers, had feared Covaxin could be ineffective or worse, slowing down New Delhi ’s campaign to inoculate 1.3 billion people. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute writes to PMO proposing reforms in drug regulatory system
In the letter, Prakash Kumar Singh, the Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII) referred to the Health Ministry's May 18, 2020, gazette notification, saying it allowed manufacturing and stockpiling of COVID-19 vaccine under clinical trial for marketing authorization for sale or distribution. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

NCPCR issues summons to DGCI over lack of uniform test for carcinogenic substances in J & J's baby products
Time and again the commission has made attempts to seek definite information on the standardised and validated method for analysing the presence of formaldehyde in baby shampoo and asbestos in talcum powder manufactured and marketed by Johnson& Johnson Private Limited, the summons issued by the NCPCR stated. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Indian leaders who got the COVID-19 vaccination shot
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Here's a status update on the current coronavirus vaccine contenders
There are at least six vaccines in advanced clinical trials and could get approval in the next couple of months. Teena Thacker& Divya Rajagopal report. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Alembic Pharma's JV Aleor Dermaceuticals gets American regulator nod for Testosterone Gel
Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its ANDA for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62%, Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Study suggests people recovered from COVID-19 respond faster to the Covishield vaccine
The study on the immune response to Covishield was carried out by researchers from New Delhi's CSIR-Institute of Genomics and Integrative Biology (IGIB), Max Super Speciality Hospital and Institute of Endocrinology, Diabetes and Metabolism as well as the Academy of Scientific and Innovative Research (AcSIR) in Ghaziabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech's corona vaccine Covaxin 81% effective
The trials involved 25,800 participants and was conducted in partnership with the Indian government's medical research body. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 3, 2021 Category: Pharmaceuticals Source Type: news

Phase 3 clinical trial: Bharat Biotech says COVID-19 vaccine shows 81% interim efficacy
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 3, 2021 Category: Pharmaceuticals Source Type: news

Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand
Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for migraine drug
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

Pfizer, Oxford vaccines reduce severe COVID-19 in elderly, study finds
The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed symptomatic disease in individuals aged 70 years or older in England. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

Lupin launches generic drug to treat Wilson's disease in US market
The Mumbai-based drug firm's product is the generic equivalent of Mylan Specialty's Depen tablets, which are indicated for the treatment of Wilson's disease, Cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

Over 1.54 crore vaccine doses administered so far, over 6 lakh on Tuesday: Government
The next phase of COVID-19 vaccination commenced on March 1 for those who are over 60 years of age and for people aged 45 and above with specified co-morbid conditions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

COVID-19 vaccine: 1.48 cr doses administered so far in India, says Health Secretary
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 2, 2021 Category: Pharmaceuticals Source Type: news

Private equity fund True North acquires minority stake in Bengaluru-based Anthem Bio
Set up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderabad based GVK Bio. Outbidding global buyout funds, private equity fund True North is all set to acquire a minority stake in Anthem Biosciences, ET reported in January. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccine supplies from India have landed in at least six African nations: Official
Addressing the 'Namaskar Africa' virtual event hosted by industry body Ficci, Rahul Chhabra -- Secretary (Economic Relations) in the Ministry of External Affairs -- also urged Indian firms to leverage the advantages presented by the Africa Continental Free Trade Area Agreement (AfCFTA) that came into effect from January 1 this year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2021 Category: Pharmaceuticals Source Type: news

Six-week sprint got Indian-made AstraZeneca vaccine approved in Canada
Last week, when Health Canada approved AstraZeneca's COVID-19 vaccine, it also cleared a version of the shot made by the Serum Institute of India (SII). SII filed the application with a Canadian partner, Verity Pharmaceuticals. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
Abevmy is abiosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2021 Category: Pharmaceuticals Source Type: news